Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
Executive Summary
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability